These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21460864)

  • 1. The role of the endothelium in the short-term complications of hematopoietic SCT.
    Carreras E; Diaz-Ricart M
    Bone Marrow Transplant; 2011 Dec; 46(12):1495-502. PubMed ID: 21460864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
    Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
    Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelium as 'novel' target of graft-versus-host disease.
    Tichelli A; Gratwohl A
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early complications following haematopoietic SCT in children.
    Miano M; Faraci M; Dini G; Bordigoni P;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S39-42. PubMed ID: 18545243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation.
    Hildebrandt GC; Chao N
    Br J Haematol; 2020 Aug; 190(4):508-519. PubMed ID: 32319084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
    Woywodt A; Haubitz M; Buchholz S; Hertenstein B
    Bone Marrow Transplant; 2004 Dec; 34(12):1015-23. PubMed ID: 15516935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment syndrome following hematopoietic stem cell transplantation.
    Spitzer TR
    Bone Marrow Transplant; 2001 May; 27(9):893-8. PubMed ID: 11436099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
    Pihusch V; Pihusch M; Penovici M; Kolb HJ; Hiller E; Pihusch R
    Thromb Res; 2005; 116(3):233-40. PubMed ID: 15935832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
    Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
    Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant.
    Watkins TR; Chien JW; Crawford SW
    Semin Respir Crit Care Med; 2005 Oct; 26(5):482-9. PubMed ID: 16267699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
    Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.
    Lesesve JF; Alla F; Dugué F; Salignac S; Clément L; Lecompte T; Bordigoni P
    Int J Lab Hematol; 2011 Aug; 33(4):343-56. PubMed ID: 21284831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
    Pericleous C; Giles I; Rahman A
    Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation.
    Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Martine C; Ghita G; Escolar G; Carreras E
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):985-93. PubMed ID: 20167280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.
    Blix ES; Husebekk A
    Leuk Lymphoma; 2016 Dec; 57(12):2752-2762. PubMed ID: 27396981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome.
    Helmy A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):11-25. PubMed ID: 16393276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capillary leak syndrome disclosing Ofuji's papuloerythroderma].
    Carsuzaa F; Pierre C; Morand JJ; Farnarier C; Marrot F; Kaplanski G
    Ann Dermatol Venereol; 1996; 123(9):559-62. PubMed ID: 9615108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
    Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.